| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |